Development of AEZS-115 (ZEN-019) by optimization of structurally unique, orally active, peptidomimetic GnRH antagonists
Adv Exp Med Biol
.
2009:611:521-2.
doi: 10.1007/978-0-387-73657-0_227.
Authors
K W Paulini
1
,
S Baasner
,
M Gerlach
,
E E Polymeropoulos
,
P Schmidt
,
T Schuster
,
M Teifel
,
E G Guenther
Affiliation
1
AEterna Zentaris GmbH, Discovery and Preclinical Development, Weismuellerstr. 50, 60314 Frankfurt am Main, Germany.
PMID:
19400294
DOI:
10.1007/978-0-387-73657-0_227
No abstract available
MeSH terms
Administration, Oral
Animals
Female
Gonadotropin-Releasing Hormone / antagonists & inhibitors*
Guinea Pigs
Male
Molecular Structure
Rats
Substances
Gonadotropin-Releasing Hormone